Publications by authors named "C Liard"

Article Synopsis
  • The study aimed to evaluate how well two university hospitals followed French guidelines to prevent infections related to central venous catheters (CVCs).
  • An observational audit was carried out in 7 wards using a digital tool to gather data on compliance.
  • Results indicated that while hand hygiene practices were generally good (90% compliance), there were notable gaps in glove use and rinsing practices; further investigation is needed to understand the barriers to following these evidence-based recommendations.
View Article and Find Full Text PDF

Background: A growing body of evidence reports that agitation and encephalopathy are frequent in critically ill Covid-19 patients. We aimed to assess agitation's incidence and risk factors in critically ill ARDS patients with Covid-19. For that purpose, we compared SARS-CoV-2 acute respiratory distress syndrome (ARDS) patients with a population of influenza ARDS patients, given that the influenza virus is also known for its neurotropism and ability to induce encephalopathy.

View Article and Find Full Text PDF

For the first time, a meeting dedicated to the tyrosine kinase receptors DDR1 and DDR2 took place in Bordeaux, a famous and historical city in the south of France. Over the course of 3 days, the meeting allowed 60 participants from 11 different countries to exchange ideas and their new findings about these unique collagen receptors, focusing on their role in various physiological and pathological conditions and addressing their mechanisms of regulation and signalling. The involvement of these receptors in different pathologies was also considered, with emphasis on cancer development and potential therapeutic applications.

View Article and Find Full Text PDF

Telomerase reverse transcriptase (TERT) is highly expressed in more than 90% of canine cancer cells and low to absent in normal cells. Given that immune tolerance to telomerase is easily broken both naturally and experimentally, telomerase is an attractive tumor associated antigen for cancer immunotherapy. Indeed, therapeutic trials using human telomerase peptides have been performed.

View Article and Find Full Text PDF